Lapatinib

CAS No.

231277-92-2

MDL No.

MFCD09264194

C₂₉H₂₆ClFN₄O₄S

581.10

InChI Key

BCFGMOOMADDAQU-UHFFFAOYSA-N

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Pack Size

Purity

Price

Availability

Action

On Request

Custom synthesis and bulk supply options are available upon request.

Product Information

Lapatinib is an organofluorine and organochlorine compound, belonging to the classes of quinazolines and furans. It functions as an antineoplastic agent and tyrosine kinase inhibitor, and is related to monofluorobenzene.

CAS No.	231277-92-2
Product Name	Lapatinib

Biological Targets

EGFR·ERBB2

Associated Conditions

brain disease·Pituitary Gland Adenoma·HER2 Positive Breast Carcinoma·Central Nervous System Neoplasm·cancer·

* The information provided here is compiled from public sources and is for reference only.

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Documentation

Lapatinib

Pricing & Availability

Product Information

Biological Profile

Safety Information

Properties

Biological Targets

Associated Conditions

Related Articles

Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.

Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance.

Gateways to clinical trials.

Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib.

Documentation

Similar Products

Tykerb